Literature DB >> 33687023

Profile of sleep-disordered breathing in ILD: Could be better with study design?

Deependra Kumar Rai1.   

Abstract

Entities:  

Year:  2021        PMID: 33687023      PMCID: PMC8098906          DOI: 10.4103/lungindia.lungindia_838_20

Source DB:  PubMed          Journal:  Lung India        ISSN: 0970-2113


× No keyword cloud information.
Sir, I read the manuscript with great interest and congratulate the authors for well-written manuscript.1 Manuscript was mentioned as prospective observational study but, in this, design of study needs to follow the same group of cohorts for some period to know the association between some factors with outcome variable. This study seems to be simple observational cross-sectional study.[2] Inclusion criteria and exclusion was not defined. What could be the region for inclusion of defined period and total study subject of 100. Was it total 100 consecutive patients diagnosed as Interstitial lung disease (ILD) in given period? Or there were any exclusion criteria like patient who already diagnosed as ILD on treatment or patient require oxygen or who denied for sleep study etc. Nocturnal Oxygen desaturation (NOD) was not defined. Nocturnal desaturation occurs frequently in ILDs especially in idiopathic pulmonary fibrosis.[34] Significant nocturnal desaturation considered when >10% of sleep with oxygen saturation (SpO2) <90%. Desaturation index was defined as the number of desaturation events >4%/h. Although 10% or more of total sleep time with SpO2 <90% has been defined as “significant” nocturnal hypoxemia and it has prognostic value in ILD, specific thresholds have not been established.[5] If this threshold used to define NOD, it should be clearly mentioned in materials and methods. Author mentioned that the mean forced vital capacity (FVC) in the study group was 53.67% predicted, 50% predicted in patients with obstructive sleep apnea (OSA), 45.56% predicted in patient having NOD without OSA, and 57.87% predicted in patients with no sleep-disordered breathing (SDB). The difference was said statistically significant with P = 0.48 (<0.5). No comment on statistical method performed for correlation and how can P = 0.48 become significant. Mean FVC was found lowest in group NOD without OSA (45.56%), Is it means that restriction is more due to Nocturnal desaturation than OSA? It is very important to know the range of data but did not find standard deviation or quartile deviation for continuous variable or categorical variable. P value was wrongly interoperated not only for FVC but also for mean 6-min walking distance, PaO2, and pulmonary arterial systolic pressure. ILD is not only associated with OSA as comorbidities but other such as diabetes, hypertension, obesity, and chronic obstructive pulmonary disease. No comment on that as it could influence the all outcome variable measured. The study was performed to assess prevalence and profile of SDB and OSA. Sleep disorder of breathing include 4 disease central sleep apnea syndromes, OSA disorders, sleep-related hypoventilation disorders, sleep-related hypoxemia disorder but no comment found on hypoventilation and central sleep apnea in whole manuscript. In last, the study was concluded as SDB in ILD is associated with a significant impact on the cardinal determinants of functional capacity, lung function, and quality of life. However, primary objective of study was prevalence of SDB in ILD and also quality of life was not assessed. Thanking you and authors!

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  5 in total

1.  Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis.

Authors:  Likurgos Kolilekas; Effrosyni Manali; Katerina A Vlami; Panagiotis Lyberopoulos; Christina Triantafillidou; Konstantinos Kagouridis; Katerina Baou; Sotirios Gyftopoulos; Konstantinos N Vougas; Anna Karakatsani; Manos Alchanatis; Spyros Papiris
Journal:  J Clin Sleep Med       Date:  2013-06-15       Impact factor: 4.062

2.  Obstructive sleep apnea is common in idiopathic pulmonary fibrosis.

Authors:  Lisa H Lancaster; Wendi R Mason; James A Parnell; Todd W Rice; James E Loyd; Aaron P Milstone; Harold R Collard; Beth A Malow
Journal:  Chest       Date:  2009-06-30       Impact factor: 9.410

Review 3.  Observational studies: cohort and case-control studies.

Authors:  Jae W Song; Kevin C Chung
Journal:  Plast Reconstr Surg       Date:  2010-12       Impact factor: 4.730

4.  Elevated nocturnal desaturation index predicts mortality in interstitial lung disease.

Authors:  T J Corte; S J Wort; S Talbot; P M Macdonald; D M Hansel; M Polkey; E Renzoni; T M Maher; A G Nicholson; A U Wells
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2012-03       Impact factor: 0.670

5.  Prevalence and profile of sleep-disordered breathing and obstructive sleep apnea in patients with interstitial lung disease at the pulmonary medicine department of a tertiary care hospital in Mumbai.

Authors:  Ketaki Utpat; Abhishek Gupta; Unnati Desai; Jyotsna M Joshi; Ramesh N Bharmal
Journal:  Lung India       Date:  2020 Sep-Oct
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.